Clinical Trial Update: Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/Phase 2 clinical trial is investigating how circadian rhythm affects responses to neoadjuvant immunotherapy in triple-negative breast cancer.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | Conditions: Triple Negative Breast Cancer (TNBC) | Phase 1, Phase 2 | Status: RECRUITING